• Sellas Life Sciences on June 24, 2026 revised severance and change-of-control terms for CEO Angelos Stergiou, CFO John Burns, CDO Dragan Cicic.
• Stergiou change-of-control severance updated to pay certain amounts in a lump sum; other employment terms unchanged.
• Burns, Cicic: termination without cause or for good reason outside a change-of-control window triggers nine months’ salary continuation, pro rata target bonus, COBRA reimbursement.
• Within one month before to one year after a change of control: 15 months’ base salary lump sum, target bonus lump sum, up to 18 months’ COBRA.
• Change-of-control severance also provides immediate full vesting of all unvested equity awards held at termination, subject to a separation and release.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sellas Life Sciences Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-077556), on June 25, 2026, and is solely responsible for the information contained therein.